| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |